You are here

Medical Monitoring, Diagnostics, and Triage

Description:

TECHNOLOGY AREA(S): Bio Medical 

OBJECTIVE: This is an AF Special Topic in partnership with MD5, please see the AF Special Topic instructions for further details specifically for requirements related to MD5 programs and services and this topic. The objective of this topic is to develop innovative systems or prototypes that address the capability to remotely monitor, rapidly diagnose, and triage medical needs of a modern warfighter. Trends toward access to mobile computing, wearable devices, materials with embedded sensors, and enhanced connectivity, etc. are critical to meeting these needs. This topic will reach companies that can complete a feasibility study and prototype validated concepts in accelerated Phase I and II schedules. A Phase I award will be completed over 3 months with a maximum award of $75K and a Phase II may be awarded for a maximum period of 15 months and $750K. Proposals that are selected for award under the MD5 Special Topics will need to have participated in an MD5 program or service, or in another technology acceleration program, prior to the completion of the proposed Phase I SBIR project as noted in the AF Special Topic instructions. 

DESCRIPTION: Within the Department of Defense (DoD), there is enormous interest in continuous monitoring, analysis, and transferring of casualty information to systems that can be autonomously implemented for triage combat and field medical response. Studies have shown that there are number of challenges not limited to ownership, data and metrics, prehospital and trauma systems, etc. In recent history of 30,000 casualties in Iraq/Afghanistan, “less than 10% of these casualties’ records had any documentation of the care that was provided before the casualty reached a medical treatment facility.” Solutions for this topic should cover one or more of the aspects of the Medical Monitoring, Diagnostics, or Triage process including (but not limited to): ● Software for improving casualty tracking and decrease errors in communication ● Real-time transfer of casualty information from point of injury to definitive care ● Improved integration of actuators and sensors into materials used to autonomously deploy treatment ● Smart diagnostics equipment to rapidly gather information and improve the level of directed care during the “golden hour” 

PHASE I: Conduct a feasibility study to determine the effectiveness of potential or existing commercial or defense solution(s) for one or more of the medical monitoring, diagnostics, and triage challenges. This feasibility study should directly address: 1. Which problem area(s) are being addressed by the solutions 2. How they will apply to the US Government’s needs 3. The breadth of applicability of the solution(s) to the US Government 4. Give examples of which government customers would likely be able to utilize the solution(s) 5. The solution(s) should also be evaluated for cost and feasibility of being integrated with current and future complementary solutions 6. How the solution(s) will be able to address potential future changes in medical technologies and challenges 7. The potential to keep pace with technological change due to things such as other non-DoD applications and customer bases for the solution(s) The funds obligated on the resulting Phase I SBIR contracts are to be used for the sole purpose of conducting a thorough feasibility study using interviews, analyses, trade studies, experiments, simulations, and/or component testing. 

PHASE II: Develop and demonstrate a prototype system determined to be the most feasible solution during the Phase I feasibility study on medical monitoring, diagnostics, and triage challenges. This demonstration should focus specifically on: 1. A clear and specific government customer that can immediately utilize the solution 2. How the solution differs from any existing technology or product to solve the DoD need (i.e. leverage of new technology or a description of how existing technology has been modified) 3. How the solution can leverage continued advances in technology 4. How the demonstrated capability can be used by other DoD customers 

PHASE III: The contractor will pursue commercialization of the various technologies developed in Phase II for transitioning expanded mission capability to a broad range of potential government and civilian users and alternate mission applications. 

REFERENCES: 

1: The Tactical Combat Casualty Care Card, http://www.dtic.mil/dtic/tr/fulltext/u2/a616640.pdf

2:  "Air Force medical research supports en route care mission" http://www.amc.af.mil/News/Article-Display/Article/1254149/air-force-medical-research-supports-en-route-care-mission/

3:  "Medical Simulation and Information Sciences Research Program (MSIS), Mission and Research Programs," http://mrmc.amedd.army.mil/index.cfm?pageid=medical_r_and_d.msis.overview

4:  "Death on the battlefield (2001-2011): implications for the future of combat casualty care." The Journal of Trauma and Acute Care Surgery, https://www.ncbi.nlm.nih.gov/pubmed/23192066

KEYWORDS: Medical Devices, Trauma, Prolonged Field Care, Tactical Combat Casualty Care, Smart Materials, Remote Monitoring 

CONTACT(S): 

Greg Coleman (MD5) 

(301) 502-1609 

gcoleman@md5.net 

US Flag An Official Website of the United States Government